ZiO Health
ZiO Health is a medical technology company focused on democratizing medical testing and health data. Their proprietary biosensor technology, combined with AI-driven machine learning algorithms, enables laboratory-grade testing at the point-of-care. This pocket-sized platform supports single-point and continuous monitoring, aiming to improve patient outcomes and optimize health. A key application is Therapeutic Drug Monitoring (TDM), specifically for vancomycin, offering AI-guided precision dosing to maximize efficacy and minimize toxicity, leading to potential cost reductions and shorter hospital stays. They also facilitate decentralized clinical trials for pharmaceutical partners, enabling patient-centric approaches and real-world evidence generation.
ZiO Health
ZiO Health is a medical technology company focused on democratizing medical testing and health data. Their proprietary biosensor technology, combined with AI-driven machine learning algorithms, enables laboratory-grade testing at the point-of-care. This pocket-sized platform supports single-point and continuous monitoring, aiming to improve patient outcomes and optimize health. A key application is Therapeutic Drug Monitoring (TDM), specifically for vancomycin, offering AI-guided precision dosing to maximize efficacy and minimize toxicity, leading to potential cost reductions and shorter hospital stays. They also facilitate decentralized clinical trials for pharmaceutical partners, enabling patient-centric approaches and real-world evidence generation.
TL;DR
What they do: Pocket-sized biosensor platform + AI models for point-of-care molecular testing and therapeutic drug monitoring (notably vancomycin)
Founded / HQ: 2016; London (UK) with a U.S. presence
Key application: Free and total vancomycin measurement with AI-guided precision dosing
Funding signal: Multiple grants and funding rounds (most recent: grant on 2024-09-26)
Company Overview
Problem Domain
Point-of-care diagnostics, therapeutic drug monitoring, decentralized clinical trials
Founded
2016
Industry
Biotechnology
Funding Track Record
Most recent listed funding event is a grant dated 2024-09-26.
Investor Signal
“Multiple grants and funding/support from accelerators and public funders (investors listed include Kidney Research UK, SOSV, HAX, Innovate UK, EIT Health, Greater London Authority, MassChallenge, PharmStars, CVX Ventures, Health Engine)”